Hepatitis B virus (HBV) genotypes show genomic variations, resulting in different CpG islands in each HBV genotypes or subgenotype. This study aimed to establish reference sequences for each HBV subgenotype of A-H genotypes and to analyze the characteristics of the CpG islands.
Background
Worldwide, hepatitis B virus (HBV) infection has high rates of morbidity and mortality and represents a serious public health issue with changes in epidemiological features resulting from factors including migration, genetic variation, and the effects of treatment [1] [2] [3] . Because of the absence of 'proofreading' activity in HBV DNA polymerase, random nucleotide misincorporation into the replicating DNA strand leads to a high mutation rate, which is estimated at between 1.4-3.2×10 -6 substitutions per site per year in the whole HBV genome [4] . Currently, HBV isolates worldwide have been divided into ten well-accepted genotypes (A to J), based on an inter-genotypic difference of greater than 8% in sequences [5] [6] [7] .
The establishment of representative reference sequences might facilitate studies on HBV infection and its pathogenicity. Certain HBV references sequences had been reported previously. However, these HBV references sequences are not truly representative, since they were either simply based on the first identified isolates or isolates of small sample sizes [8-15. Considering representativeness and consistency, we previously established reference sequences of HBV genotypes A (A1, A2, A3, A5), B2, and C (C1, C2, C5, C6) on the basis of large numbers HBV sequences, and deposited them in GenBank, with GenBank accession codes being KP234050-KP234053 (A1, A2, A3, A5) and KM999990-KM999993 (C1, C2, C5, C6) [15] [16] [17] . The synthesized consensus genome of subgenotype (subtype) B2 is replication-competent upon transfection into hepatoma cells in vitro and expression and replication in mice [18] . Representative reference sequences of other genotypes still need to be established. Viral gene expression is believed to be partially regulated by DNA methylation, which usually occurs in the promoter region leading to transcriptional silencing and gene repression, via multiple mechanisms in human tissues [19] . DNA methylation frequently occurs in the CpG dinucleotide-rich region known as the CpG island. Currently, six CpG islands, including three newly identified CpG islands (IV, V, and VI), are generally accepted to exist. These CpG islands are located at the transcription start site or are located upstream and downstream of the promoters [20] [21] [22] . Host DNA methyltransferase mediates CpG methylation, and methylated HBV CpG islands limit their regulation of viral protein expression [23, 24] . Agents promoting methylation of nuclear HBV DNA may constitute another new antiviral treatment modality than nucleotide analog drugs and interferons [25] .
This study aimed to establish standard sequences between HBV subtypes and to further clarify CpG-enriched sites in the HBV genome in subtypes of HBV genotypes A-H. The location, length, and distribution of CpG islands in the genome of individual subtypes and their representative strains were investigated. Comparative analysis of CpG islands was performed among the reference sequences and representative strains of HBV genotypes A-H. The data from this study might provide insights into the clinicopathological and virological characteristics of distinct HBV genotypes and subtypes.
Material and Methods

Sequence sources and criteria
The GenBank Nucleotide Database was searched up to December 1, 2013 , at the National Center for Biotechnology Information, using the keywords, 'hepatitis B virus,' 'genotype,' and 'complete genome.' Complete genome sizes ranging from 3100-3300 bp were included.
Establishment of hepatitis B virus (HBV) subtype references
Reference sequences of eight subtypes of HBV genotypes C and A were created in 2015 and 2016, respectively [16, 17] . Using a similar method, phylogenetic and molecular phylogenetic analysis was conducted using the Maximum Likelihood statistical method and Tamura-Nei model, with 1000 bootstrap replicates, using the MEGA version 7 software (Kumar, Stecher, and Tamura 2015). All sequences were compared with known HBV references including A1 (KP234050), Aafr (AF297621), Bj (AB073858), C2 (KM999991), C (AB033556), D (X02496), E (X75657), F (X69798), G (AF160501), and H (AY090454), to determine the subtypes they belonged to. Finally, 1,680 strains belonging to 20 subtypes of HBV genotypes B, D-H were identified.
All strains in each subtype were aligned using the AlignX software, a component of Vector NTI Advance11.5 (Thermo Fisher Scientific, Waltham, MA, USA), using the ClustalW algorithm. The nucleotide in each position of the reference sequence of each subtype was determined on the basis of the nucleotide with the highest frequency in the corresponding position. Phylogenetic trees of the whole genome and S gene of 28 HBV subtype reference sequences were constructed using the Unweighted Pair Group Method with Arithmetic Mean method with 1000 bootstrap replicates, using MEGA 7 software.
Computation of CpG islands
A pool of strains was selected from the 3,037 strains based on which reference sequences were established, and all CpG islands were identified in them. To construct this pool, 50 strains were randomly selected from a certain subtype if that subtype had more than 50 strains, and all were selected if a subtype had less than 50 strains. In total, 939 strains from 28 HBV subtypes were selected. The CpG islands were computed using two online methods, the MethPrimer (www.urogene.org/ cgi-bin/methprimer/methprimer.cgi) and the CpG Plot (www. ebi.ac.uk/Tools/seqstats/emboss_cpgplot). The criteria used to distinguish a CpG island included a GC content of ³50%, the observed/expected CpG dinucleotide of ³0.6, and a window size of ³100 bp [23, 26] . Information regarding the size, number, location, and other features of CpG islands in the reference sequences of HBV subtypes and selected strains were further collected. CpG islands were classified primarily by their positions in the reference sequences. Identities of CpG islands proximal to one another, separated by a boundary, were determined on the basis of positions where major regions of those islands were located.
Statistical analysis
The chi-squared (c 2 ) test was performed using SPSS version 16.0 (IBM, New York, USA) for the composition of the CpG islands among the various subtypes. Non-parametric tests were performed using SPSS version 16.0 (IBM, New York, USA) for D1I is D1 India, D1M is D1 Middle East. S, X, P, C is S, X, P, C regions of HBV DNA genome. '-' The same as the number before the first occurrence of the symbol in this column.
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the length and position of each CpG island of each genotype to determine whether CpG islands showed significant diversity between different subtypes of the same HBV genotype. Statistical significance was defined as P<0.05.
Results
Characteristics of the strains of hepatitis B virus (HBV)
In total, 3,037 whole-genome sequences of HBV A-H genotypes met the selection criteria and were included in the analysis.
Among them, 1,357 belonged to genotypes A and C; 1,680 belonged to genotypes B, D-H ( Table 1 ). The geographic distribution has been summarized in Supplementary Among the 28 reference sequences, genome lengths were different. However, the lengths of S and X genes were the same, with 681 and 465 bases coding for 226 and 465 amino acids, respectively ( Table 1 ). The phylogenetic relationship between whole genomes and S genes among 28 reference sequences is shown in Figure 1A . The phylogenetic relationship of the S region is very similar to that of the whole genome, but with some minor differences. Their clustered tendency was similar to those reported previously [21] .
Characteristics of the CpG islands
Of 28 reference sequences, each had 2-3 CpG islands. Among them, 17 (60.71%) contained three traditional CpG islands I, II, and III, while 11 other subtypes (39.29%) lacked a CpG island I (Table 3 , Figure 1B ). Only subtype F4 contained a new island, CpG island V (located at sites 1933-2036). In most of the reference sequences, the position and size of CpG islands II and III were similar. However, significant differences existed in those of CpG island I (Table 3) .
Of the 939 selected strains, each strain contained 1- Table 2 ).
CpG islands I and IV had a wide range of start and end sites and overlaps frequently occurred between the start and end sites of these CpG islands among different strains. The standard A1 (50) A2 (50) A3 (22) A5 (25) B2 (50) B3 (23) B4 (17) B1 (24) B6 (39) B7 (13) B9 (19) C1 (50) C2 (50) C5 (9) C6 (17) D1 I (50) D1 M (50) D3 (50) D5 (31) D2 (50) D7 (33) E (50) F1 (50) F2 (18) F3 (21) F4 (28) G (28) .01, and 38.87, respectively, on using SPSS version 16.0. Based on the range and SD of the start site, CpG islands I and IV showed the highest dispersion, consistent with the distribution of CpG island I among different reference sequences. The start site of CpG island IV with or without island I displayed no significant difference in a rank sum test (P=0.413). Because CpG island IV was downstream of CpG island I, a similar analysis was performed for the start sites of CpG island IV and end sites of CpG island I of all strains containing CpG island IV displaying a significant difference (P<0.001). Therefore, CpG islands I and IV were considered not to be the same island.
The absence of CpG island I
Among 939 selected strains, 423 (45.05%) lacked CpG island I. Specifically, 100% of strains of subtypes C5, F1-F4 and genotype H, and more than 75% strains of subtypes A3, A5, C1, C2, and genotype G, respectively, but less than 48% strains of other (sub)genotypes lacked CpG island I. B7 was the only subtype where all strains contained CpG island I (Table 2 ) ( Figure 3A) . With respect to the genotype, CpG island I was lacking in 43.54% (A), 11.35% (B), 76.98% (C), 25.76% (D), 16% (E), 100% (F), 92.86% (G) and 100% (H). Overall, CpG island I was most frequently absent in genotypes C, F, G, and H. Strains with new islands accounted for 13.24% (56/423) of those without a CpG island I, and 11.82% (61/516) of those with a CpG island I. A chi-squared test was performed, but the differences were not statistically significant (P=0.513).
Characteristics of new CpG islands
Of the 939 selected strains, 117 (12.46%) contained 120 new CpG islands. Figure 3 ). Sixty-five strains of HBV genotypes A-F and H contained CpG island IV. Among genotypes B, C, D, F, and H, 47 strains contained CpG island V, primarily distributed in B6 (12/47) and F4 (22/47). Eight strains from genotypes A-C contained CpG island VI (two in genotypes A5 and B7, six in genotype C). GQ924641 (B3, no CpG island I), DQ463802 (B6, having CpG island I) and AB516395 (H, no CpG island I) contained two new islands: CpG islands IV and V. The distribution, median, and 95% range of the start site, end site, and length of CpG islands IV, V, and VI are shown in Table 4 and Figures 2, 4 .
Since the differences in CpG island I and new islands were greater than those in CpG islands II and III among each subtype, the chi-squared analysis was performed for the composition ratios of strains with or without CpG island I or new islands between subtypes of the same HBV genotype in this study ( Figure 3A ). The strains with CpG islands I, II, and III, and new islands among subtypes of each genotype were also 
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analyzed via a similar chi-squared test ( Figure 3B ). Figure 3A shows that the composition of strains with or without CpG island I or new CpG islands in each subtype of the same genotype was significantly different (P<0.05). However, there was no significant difference between some subtypes (P>0.05).
The information provided in Figure 3B is not the same as in Figure 3A . It is evident that there were no significant differences in the composition of strains containing CpG islands I, II, and III and new islands among the subtypes of HBV genotypes B and D (P>0.05), while genotypes A, C, and F showed the opposite trend (P<0.05).
Discussion
Methylation is a major form of epigenetic modification of genomic DNA, which serves as an important means for functional regulation of the genome and is believed to be involved in the cellular resistance to viral DNA invasion into the nucleus [27] . CpG island methylation of hepatitis B virus (HBV) DNA has been shown to play important roles in regulating the adaptability of the virus, silencing transcription, and down-regulating viral replication [23, [28] [29] [30] . DNA methylation is related to the specific location of CpG in mammals [31] , and the distribution of CpG islands might affect HBV genome methylation. Also, studies have shown that CpG islands of HBV DNA are divergent among different genotypes, which might partially account for the difference in clinical outcome among different HBV genotypes [21] .
The absence of CpG island I is common in genotypes A, C, F, G and H, and new CpG islands are common in genotypes B, C, E, F, H, but rare in A, D, and G [21, 22] . However, the findings of the present study showed that there were significant differences between specific subtypes, and that every subtype may possess a different CpG island distribution within the same genotype ( Figure 1B) . Also, the results of the chisquared test also showed that there were significant differences in CpG island composition among the various subtypes in the same genotype. For example, the absence rates of CpG island I were very high in subtypes C1, C2, and C5, but very low in subtype C6. The CpG island I absence rate in genotype B ranged from 0 (B7) to 35% (B4), genotype D range from 3% (D5) to 48% (D2). Therefore, the characteristics of CpG islands in HBV subtypes may be more accurate than that of its genotypes. Previously, the synthesized genome of the B2 subtype has been shown to be fully replication-competent by in vitro transfection into hepatoma cells, in addition to expression and replication in mice [18] . Therefore, the large number of features of HBV subtypes reference sequences and CpG islands obtained in this study may provide a more substantial theoretical basis for HBV methylation research.
Previous studies that have compared infections caused by HBV genotypes B and C found that infections with genotype B resulted in earlier hepatitis B e antigen (HBeAg) seroconversion, whereas infections with genotype C had an increased risk of developing cirrhosis and hepatocellular carcinoma (HCC) [32] [33] [34] .
Other studies have speculated that this may be related to the increased absence rate of CpG island I in HBV genotype C [21] .
From the previously published data and the findings of this study, HBV genotypes B and C are mostly distributed in China, and mainly include the B2, C1, and C2 subtypes (Supplementary Table 1 ). Consistent with previous findings, the present study showed that the rate of absence of CpG island I in HBV subtypes C1 and C2 was greater when compared with that in subtype B2. Therefore, it is possible to infer that the infection with HBV subtypes A3, A5 and genotypes F, G and H will result in similar clinical outcomes when compared with subtype C, showing a higher risk of developing cirrhosis and hepatocellular carcinoma (HCC) ( Figure 3A ). Two previously published clinical studies have shown an association between HBV genotype F and severe liver disease and HCC, and have shown that the risk of the development of HCC associated with HBV infection was significantly greater for genotype F than for genotypes A-D [35, 36] . However, the function of CpG island I remain unclear, and how the absence of CpG island I facilitates the development of cirrhosis and HCC in HBV infection in patients requires further research.
The data obtained in the present study showed that CpG islands I-III among different subtypes in the almost all of HBV genotype showed significant differences (P<0.05), except for the CpG island I of genotype C (Supplementary Table 2 ). Figure 2 illustrates the same phenomenon in which the start sites of HBV subtypes B2 and B6 strains are focused around the same site, with the end sites being scattered. This phenomenon also appears widely in other CpG islands of other HBV subtypes, and the relationship between these occurrences and the different outcomes of infection with different HBV genotypes or the same genotype remain unclear.
This study had several limitations. All data analyzed were downloaded from GenBank, and the number of strains in some HBV genotypes and subtypes was small. Also, this study was a theoretical analysis of the differences in CpG islands, which are potential methylation sites between the various genotypes, and the possible impact of the findings on clinical outcomes was not specifically studied.
Although CpG islands of HBV strains from a specific subtype were quite different, the major distribution tendency of the start and end sites and the lengths of CpG islands were consistent with those of corresponding subtype reference sequences. This finding indicated that the reference sequences used in this study were reliable, representative of the general characteristics of strains from respective HBV subtypes, and suitable to serve as models and tools for evaluation of subtype-specific CpG islands as possible targets for methylation. Importantly, these sequences could be used for the investigation of potential roles of HBV DNA methylation in the clinical course of HBV infection.
Conclusions
The present study established 28 subtype reference sequences of HBV genotypes A-H. The composition of strains with or without CpG island I, or new islands between different subtypes within the same HBV genotype, showed significant differences. CpG islands I-III among different subtypes in almost all HBV genotypes showed significant differences, except for the CpG island I in genotype C. The findings of this study might provide a foundation for further studies on the role of HBV DNA methylation in determining subtype-specific HBV viral biology, immune reactions against HBV infection, the clinical course of HBV infection, and drug sensitivity.
